News
-
Dispensary Corner 08 Jan 25
Wednesday | Jan 8 2025COFFEE addicts will be pleased to know that their caffeine-guzzling habit could reduce the risk of dementia later in life - but only if you have an irregular heart rhythm.
-
Make injections a breeze with NeedleCalm
Wednesday | Jan 8 2025MAKE injections a breeze with NeedleCalm - Australian made & award-winning medical device.
-
Pyridox — Vitamin B6 supplement
Wednesday | Jan 8 2025PYRIDOX helps to relieve premenstrual symptoms such as cramps, breast tenderness, fluid retention, irritability and mood swings.
-
Guild deal mitigates closures
Wednesday | Jan 8 2025NEW figures from the Department of Health and Ageing show that 22 pharmacies across the country closed during the eight months since the Federal Government's 60-day double dispensing policy took effect.
-
Aussie start-up nabs Sigma as client
Tuesday | Jan 7 2025SIGMA is the latest pharmacy group to join Locumate.ai, a Melbourne start-up specialising in pharmacy talent automation.
-
Pfizer drug linked to tumours
Tuesday | Jan 7 2025PFIZER could face legal action in Australia after its popular contraceptive, Depo-Provera, was linked to brain tumours.
-
One cig costs you 20 min
Tuesday | Jan 7 2025CIGARETTE smokers are being urged to heed new research out of the UK, which shows that every cigarette smoked, on average, can take around 20 minutes off their life expectancy.
-
PBS push for weight loss drugs
Tuesday | Jan 7 2025AMERICAN pharmaceutical company Eli Lilly is pushing for its weight-loss drug, Mounjaro, to be subsidised by Australia's Pharmaceutical Benefits Scheme (PBS) for people with severe obesity.
-
Big pharma turns blind eye to AMR
Tuesday | Jan 7 2025THERE is currently no incentive for pharmaceutical companies to develop new antibiotics, England's former Chief Medical Officer, Sally Davies, has emphasised, amid warnings that the global death rate from antimicrobial resistance (AMR) is expected to double to 40 million by 2050 (PD 19 Sep 2024).
-
Parkinson’s relief
Tuesday | Jan 7 2025KETAMINE could benefit patients with Parkinson's disease, potentially helping the motor cortex to regain some control over movement, new research from the University of Arizona has uncovered.
